Page last updated: 2024-10-30

mesalamine and Orphan Diseases

mesalamine has been researched along with Orphan Diseases in 1 studies

Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.

Orphan Diseases: Rare diseases that have not been well studied.

Research Excerpts

ExcerptRelevanceReference
"At least 1% of patients with Crohn's disease develop amyloidosis."2.45Crohn's disease and secondary amyloidosis: early complication? A case report and review of the literature. ( Basturk, T; Kusaslan, R; Ozagari, A; Ozturk, T; Unsal, A, 2009)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Basturk, T1
Ozagari, A1
Ozturk, T1
Kusaslan, R1
Unsal, A1

Reviews

1 review available for mesalamine and Orphan Diseases

ArticleYear
Crohn's disease and secondary amyloidosis: early complication? A case report and review of the literature.
    Journal of renal care, 2009, Volume: 35, Issue:3

    Topics: Adult; Amyloidosis; Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Colchicine; Crohn Disease; Dise

2009